tyrosine has been researched along with Angiogenesis, Pathologic in 88 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.14) | 18.7374 |
| 1990's | 5 (5.68) | 18.2507 |
| 2000's | 48 (54.55) | 29.6817 |
| 2010's | 29 (32.95) | 24.3611 |
| 2020's | 5 (5.68) | 2.80 |
| Authors | Studies |
|---|---|
| Dembélé, P; Garnier, O; Martin, DK; Vilgrain, I | 1 |
| Duda, DG; Jain, RK | 1 |
| Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
| Fujiwara, K; Kobayashi, M; Nakayama, M; Sato, Y; Suzuki, Y; Wakabayashi, I; Watabe, T | 1 |
| Claesson-Welsh, L; Hedlund, M; Love, DT; Ninchoji, T; Sessa, WC; Smith, RO; Vestweber, D | 1 |
| Huang, H; Ma, J; Shen, P; Shi, C; Wang, Y; Xiang, H | 1 |
| Arinze, N; Belghasem, M; Chitalia, VC; Cifuentes, D; Francis, J; Ghumman, S; Hartshorn, K; Jiangliu, Y; Kolachalama, VB; Kuhnen, A; Kumaradevan, S; Lee, SY; Lyle, C; Rahimi, N; Richards, S; Tapan, U; Walker, J; Weinberg, J; Zhao, Q | 1 |
| Borges, B; de Souza, LE; Licks, F; Marques, C; Marroni, CA; Marroni, NP; Zattoni, I | 1 |
| Agarwal, R; Bhat, TA; Nambiar, D; Pal, A; Singh, RP; Tailor, D | 1 |
| Dreesen, JD; Ergun, S; Giebel, B; Jastrow, H; Muturi, HT; Nilewski, E; Singer, BB | 1 |
| Castela, Â; Costa, R; Duarte, D; Gomes, P; Guardão, L; Guimarães, JT; Magalhães, PJ; Negrão, R; Rodrigues, JA; Soares, R; Valente, I | 1 |
| Aldasoro, M; Fernández, N; Ferrero, E; Ferrero, JL; García-Villalón, AL; García-Villar, O; Granado, M; Hidalgo, M; Mauricio, MD; Monge, L; Vila, JM | 1 |
| Donnola, S; Eswarappa, SM; Fan, Y; Fox, PL; Gong, Y; Hambardzumyan, D; Lathia, JD; Potdar, AA; Rich, JN | 1 |
| Akbani, R; Armaiz-Pena, GN; Baggerly, KA; Bottsford-Miller, J; Coleman, RL; Dalton, HJ; DeGeest, K; Diao, L; Kang, Y; Lopez-Berestein, G; Lutgendorf, S; Nick, AM; Sanguino, AM; Sood, AK; Stone, RL; Thanapprapasr, D; Zand, B | 1 |
| Bruchard, M; Ghiringhelli, F | 1 |
| Batista, WL; Borges, RE; Costa, PE; Curcio, MF; Fonseca, FV; Monteiro, HP; Moraes, MS; Paschoalin, T; Stern, A; Taha, MO | 1 |
| Ahmad, S; Ahmed, A; Ahmed, SF; Al-Ani, B; Cai, M; Cudmore, M; Fujisawa, T; Gueron, G; Hewett, PW; Otterbein, LE; Ramma, W; Sissaoui, S; Vítek, L; Wang, K; Wegiel, B; Wong, MK | 1 |
| Li, JX; Miao, ZH; Wang, Y; Wang, YQ | 1 |
| Chan, LY; Lai, KN; Lan, HY; Leung, JC; Li, RX; Tang, SC; Wong, DW; Wu, HJ; Yam, I; Yiu, WH | 1 |
| Colares, JR; da Silva, J; Fisher, C; Hartmann, RM; Licks, F; Marques, C; Marroni, NP; Reys, J; Schemitt, E; Soares, Mdo C | 1 |
| Andrukhov, O; Dard, M; Gemperli, AC; Jonke, E; Özdemir, B; Rausch-Fan, X; Zhang, T | 1 |
| Dutta, U; Shaw, LM | 1 |
| Meyer, RD; Rahimi, N; Sacks, DB | 1 |
| Eliceiri, BP; Levin, EG; Lin, AH | 1 |
| Chen, YK; Lee, MJ; Li, GX; Liu, A; Loy, S; Lu, G; Picinich, SC; Xiao, H; Yang, CS | 1 |
| Baek, YH; Choi, DY; Huh, JE; Lee, JD; Lee, MH; Park, DS | 1 |
| Arjunan, P; Chavakis, T; Colosi, P; Dong, L; Hou, X; Kumar, A; Langer, HF; Lee, C; Li, X; Li, Y; Maminishkis, A; Min, W; Tang, Z; Wang, L; Wu, Z; Zhang, F; Zhu, LY | 1 |
| Alves, LA; Chung, WT; Lopes de Carvalho, A; Lopes, A; Nakagawa, SA; Rossi, BM; Soares, FA; Werneck da Cunha, I | 1 |
| El Sayed, KA; Meyer, SA; Ramasahayam, S; Sallam, AA | 1 |
| Husain, D; Meyer, RD; Rahimi, N | 1 |
| Arita, Y; Fujio, Y; Hashimoto, T; Higuchi, K; Hirano, T; Kidoya, H; Kodama, T; Komuro, I; Kuroda, T; Minami, T; Mochizuki, N; Morishita, R; Naito, H; Nakaoka, Y; Nishida, K; Shioyama, W; Shirai, M; Sonobe, T; Takakura, N; Taniyama, Y; Yamauchi-Takihara, K | 1 |
| Morimoto, J; Otsuki, Y; Shibata, MA; Tanaka, Y | 1 |
| Balan, V; Kho, DH; Nangia-Makker, P; Raz, A; Wang, Y | 1 |
| Cejka, C; Cejková, J; Luyckx, J | 1 |
| Caron, C; Chabot, C; Elchebly, M; Gavard, J; Hebda, JK; Langlois, S; Lapointe, L; Royal, I; Spring, K; Trinh, NT | 1 |
| Pfister, C; Pfrommer, H; Roser, F; Tatagiba, MS | 1 |
| Aggarwal, BB; Gupta, SC; Phromnoi, K | 1 |
| Ahmed, N; Bailey, J; Duraisamy, Y; Gaffney, J; Slevin, M; Smith, C; Smith, N; Zweit, J | 1 |
| Bråkenhielm, E; Cao, R; Cao, Y; Eriksson, U; Li, X; Ostman, A; Pietras, K; Widenfalk, J | 1 |
| Addicks, K; Bloch, W; Ehsan, A; Engelmann, U; Jacobs, G; Klotz, T; Koslowski, J; Niggemann, S; Schmidt, A; Sommer, F | 1 |
| Davies, G; Jiang, WG; Lane, J; Mansel, RE; Martin, TA; Matsumoto, K; Nakamura, T; Parr, C; Watkins, G | 1 |
| Davies, G; Jiang, WG; Lane, J; Martin, TA; Mason, MD; Matsumoto, K; Nakamura, T; Parr, C; Watkins, G | 1 |
| Alitalo, K; Claesson-Welsh, L; Dixelius, J; Karkkainen, MJ; Makinen, T; Wernstedt, C; Wirzenius, M | 1 |
| Meydani, M; Nguyen, N; Tang, FY | 1 |
| Danilovic, A; Dantas, AP; Dantas, K; Laurindo, FR; Leite, PF; Marklund, S; Moriel, P | 1 |
| Fukushima, N; Ishibashi, T; Kondo, M; Nishihira, J; Sato, Y; Sun, B; Suzuki, M; Todo, S | 1 |
| Ahn, JH; Byun, SM; Chang, SI; Chung, SI; Hong, SW; Hong, YK; Joe, YA; Jung, KH; Kim, JS; Lee, HJ; Lee, SK; Yoon, Y; Yu, HK | 1 |
| Kwon, HJ; Lee, HS; Shim, JS; Shin, J | 1 |
| Bentley, MD; Caplice, N; Chade, AR; Lerman, A; Lerman, LO; Napoli, C; Ritman, EL; Rodriguez-Porcel, M; Sica, V; Zhu, XY | 1 |
| Freeman, AL; Koolpe, M; Lu, M; Noren, NK; Pasquale, EB | 1 |
| Fidler, IJ; Yokoi, K | 1 |
| Hall, H; Hubbell, JA | 1 |
| Alexander, RW; Ushio-Fukai, M | 1 |
| Koh, Y; Koizumi, F; Nishio, K; Saijo, N; Taguchi, F; Tamura, T | 1 |
| Isoe, T; Kamishohara, M; Kubo, K; Miura, T; Nakamura, K; Shibuya, M; Taguchi, E; Takahashi, K; Yamamoto, A | 1 |
| Kanda, S; Kanetake, H; Matsuyama, T; Miyata, Y; Mochizuki, Y; Nakamura, T | 1 |
| Berge, T; Bohman, S; Bruheim, S; Claesson-Welsh, L; Dimberg, A; Dixelius, J; Magnusson, P; Matsumoto, T; Mugishima, H; Mukhopadhyay, D; Qi, JH; Spurkland, A; Wang, L; Wernstedt, C; Wikner, C; Wu, J | 1 |
| Afkhami, T; Basile, JR; Gutkind, JS | 1 |
| Cheng, G; Hsieh, FC; Lin, J | 1 |
| Ding, J; Li, L; Lin, L; Sun, P; Tian, F; Tong, Y; Yi, Y; Zhang, S; Zhang, X | 1 |
| Chiarle, R; Inghirami, G; Levy, DE; Piva, R; Schlessinger, K; Simmons, WJ | 1 |
| Corley, KM; Lilly, B; Taylor, CJ | 1 |
| Meyer, RD; Mohammadi, M; Rahimi, N | 1 |
| Boulton, M; Cai, J; Grant, MB; Jiang, WG | 1 |
| Feldmann, M; Grosjean, J; Kiriakidis, S; Paleolog, E; Reilly, K | 1 |
| Huber, P; Vilgrain, I; Wallez, Y | 1 |
| Gruman, LM; Hendrix, MJ; Hess, AR; Kinch, MS; Seftor, EA; Seftor, RE | 1 |
| Aoki, S; Cho, SH; Gao, JQ; Kobayashi, M; Kuwano, M; Kuwano, T; Mayumi, T; Nakagawa, S; Nakao, S; Ono, M; Shibuya, M | 1 |
| Bernard-Trifilo, JA; Cheresh, DA; Chi, A; Hanson, DA; Hsia, DA; Ilic, D; Lim, ST; Mikolon, D; Mitra, SK; Molina, JE; Schlaepfer, DD; Stupack, DG | 1 |
| Brulé-Donneger, S; Chaigneau, T; Charnaux, N; Friand, V; Gattegno, L; Kraemer, M; Nahon, P; Poiré, A; Saffar, L; Sainte-Catherine, O; Salzmann, JL; Sutton, A; Vassy, J; Ziol, M | 1 |
| Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT | 1 |
| Giorgetti-Peraldi, S; Hasseine, LK; Longnus, S; Murdaca, J; Suavet, F; Van Obberghen, E | 1 |
| Gao, Y; Gu, HY; Guo, QL; Ling, Y; Lu, N; Wang, XT; Yang, Y; You, QD; Zhao, L | 1 |
| Bhat, HK; Ganju, RK; McHugh, K; Paruchuri, V; Polyak, K; Prasad, A | 1 |
| Brantley-Sieders, DM; Chen, J; Fang, WB; Ham, AJ; Hwang, Y | 1 |
| Ciomei, M; Grandi, M; Mariani, M; Mongelli, N; Pastori, W; Sola, F | 1 |
| Aslakson, CJ; Elstad, CA; Meadows, GG; Starkey, JR | 1 |
| Alessandro, R; Kohn, EC; Liotta, LA; Spoonster, J; Wersto, RP | 1 |
| Brugge, JS; Foster, D; Mukhopadhyay, D; Sukhatme, VP; Tsiokas, L; Zhou, XM | 1 |
| Ambs, S; Bennett, WP; Billiar, TR; Felley-Bosco, E; Harris, CC; Klein, S; Merriam, WG; Ogunfusika, MO; Oser, SM; Shields, PG | 1 |
| Date, K; Kuba, K; Matsumoto, K; Nakamura, T; Shimura, H; Tanaka, M | 1 |
| Nag, S; Picard, P; Stewart, DJ | 1 |
| Carles-Kinch, K; Gardner, LM; Hendrix, MJ; Hess, AR; Kinch, MS; Schneider, GB; Seftor, EA; Seftor, RE | 1 |
| Birnby, LM; Milonovich, WL; Narendran, A; Phillips, PG | 1 |
| Aust, G; Nieber, K; Schilling, N; Spanel-Borowski, K; Tscheudschilsuren, G | 1 |
| Dinney, CP; Fan, Z; Hicklin, DJ; Izawa, JI; Karashima, T; Kedar, D; Kim, SJ; Pettaway, C; Shuin, T; Slaton, JW; Sweeney, P | 1 |
| Bertrand, M; Demopoulos, LA; DiBattiste, PM; Grines, CL; Harris, KE; Herrmann, HC; Meier, B; Moliterno, DJ; Powers, ER; Roffi, M; Topol, EJ | 1 |
| Belin, D; Montesano, R; Orci, L; Pepper, MS; Vassalli, JD | 1 |
5 review(s) available for tyrosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
[Impact of chemotherapies on immunosuppression and discovery of new therapeutic targets].
Topics: Animals; Carrier Proteins; CD4-Positive T-Lymphocytes; Deoxycytidine; Epoxy Compounds; Fluorouracil; Gemcitabine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Inflammasomes; Interleukin-17; Interleukin-1beta; Mice; Myeloid Cells; Neoplasms; Neovascularization, Pathologic; NLR Family, Pyrin Domain-Containing 3 Protein; Tyrosine | 2014 |
Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase.
Topics: Angiotensins; Animals; Endothelium, Vascular; Humans; Hydrogen Peroxide; Inflammation; Membrane Glycoproteins; Models, Biological; NADPH Oxidase 2; NADPH Oxidases; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Reactive Oxygen Species; Signal Transduction; Transcription, Genetic; Tyrosine; Vascular Endothelial Growth Factor A | 2004 |
New and old functions of STAT3: a pivotal target for individualized treatment of cancer.
Topics: Animals; Cell Cycle; Cell Survival; Fibroblasts; Gene Expression Regulation, Neoplastic; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Signal Transduction; STAT3 Transcription Factor; Tyrosine | 2005 |
Angiogenesis: the VE-cadherin switch.
Topics: Antigens, CD; Atherosclerosis; Cadherins; Capillary Permeability; Cell Cycle; Endothelial Cells; Endothelium, Vascular; Gene Expression Regulation; Humans; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
3 trial(s) available for tyrosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
c-Cbl Expression Correlates with Human Colorectal Cancer Survival and Its Wnt/β-Catenin Suppressor Function Is Regulated by Tyr371 Phosphorylation.
Topics: Animals; Apoptosis; beta Catenin; Biomarkers, Tumor; Case-Control Studies; Cell Proliferation; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Male; Middle Aged; Mutation; Neovascularization, Pathologic; Phosphorylation; Prognosis; Proto-Oncogene Mas; Proto-Oncogene Proteins c-cbl; Survival Rate; Tumor Cells, Cultured; Tyrosine; Wnt1 Protein; Zebrafish | 2018 |
Impact of different platelet glycoprotein IIb/IIIa receptor inhibitors among diabetic patients undergoing percutaneous coronary intervention: : Do Tirofiban and ReoPro Give Similar Efficacy Outcomes Trial (TARGET) 1-year follow-up.
Topics: Abciximab; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Combined Modality Therapy; Coronary Circulation; Diabetes Complications; Diabetes Mellitus; Diabetic Angiopathies; Female; Follow-Up Studies; Humans; Immunoglobulin Fab Fragments; Insulin; Integrins; Kinetics; Male; Middle Aged; Neovascularization, Pathologic; Platelet Glycoprotein GPIIb-IIIa Complex; Stents; Survival Analysis; Tirofiban; Treatment Outcome; Tyrosine | 2002 |
81 other study(ies) available for tyrosine and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Microtumor Spheroids Provide a Model for Studying Molecules Involved in Vascular Organization: An Illustrative Study for VE-cadherin.
Topics: Animals; Antigens, CD; Cadherins; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Sunitinib; Tyrosine | 2022 |
Revisiting Antiangiogenic Multikinase Inhibitors in the Era of Immune Checkpoint Blockade: The Case of Sorafenib.
Topics: Angiogenesis Inhibitors; Endothelial Cells; Humans; Immune Checkpoint Inhibitors; Immunotherapy; Liver Neoplasms; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Receptor Protein-Tyrosine Kinases; Sorafenib; Tyrosine | 2022 |
Tubulin carboxypeptidase activity of vasohibin-1 inhibits angiogenesis by interfering with endocytosis and trafficking of pro-angiogenic factor receptors.
Topics: Angiogenesis Inducing Agents; Angiogenesis Inhibitors; Animals; Carboxypeptidases; Cell Cycle Proteins; Cell Movement; Endocytosis; Human Umbilical Vein Endothelial Cells; Humans; Kinetics; Mice; Microtubules; Models, Biological; Mutant Proteins; Neovascularization, Pathologic; Phosphorylation; Signal Transduction; Tubulin; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2021 |
eNOS-induced vascular barrier disruption in retinopathy by c-Src activation and tyrosine phosphorylation of VE-cadherin.
Topics: Adherens Junctions; Amino Acid Motifs; Animals; Antigens, CD; Cadherins; Capillary Permeability; CSK Tyrosine-Protein Kinase; Endothelial Cells; Endothelium, Vascular; Humans; Mice; Mice, Inbred C57BL; Mice, Knockout; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Retinal Diseases; Tyrosine; Vascular Endothelial Growth Factor A | 2021 |
ECSM2, an endothelial specific VE-cadherin binding protein, has a tyrosine phosphorylation site essential to cell migration.
Topics: Antigens, CD; Apoptosis Regulatory Proteins; Cadherins; Carcinoma, Hepatocellular; Cell Culture Techniques; Cell Movement; Endothelial Cells; Endothelium, Vascular; Human Umbilical Vein Endothelial Cells; Humans; Liver Neoplasms; Membrane Proteins; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphorylation; Protein Binding; Tyrosine; Vascular Endothelial Growth Factor A | 2018 |
Antioxidant properties of glutamine and its role in VEGF-Akt pathways in portal hypertension gastropathy.
Topics: Animals; Antioxidants; Disease Models, Animal; Esophageal and Gastric Varices; Glutamine; Glutathione; Hypertension, Portal; Male; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Signal Transduction; Stomach; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Time Factors; Tyrosine; Vascular Endothelial Growth Factor A | 2013 |
Acacetin inhibits in vitro and in vivo angiogenesis and downregulates Stat signaling and VEGF expression.
Topics: Animals; Antineoplastic Agents; Capillaries; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Collagen; Drug Combinations; Endothelial Cells; Flavones; Human Umbilical Vein Endothelial Cells; Humans; Laminin; Male; Mice; Microscopy, Fluorescence; Neoplasm Invasiveness; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Phosphorylation; Proteoglycans; Rats; Rats, Wistar; Signal Transduction; STAT1 Transcription Factor; STAT3 Transcription Factor; Tyrosine; Vascular Endothelial Growth Factor A | 2013 |
Tumor and endothelial cell-derived microvesicles carry distinct CEACAMs and influence T-cell behavior.
Topics: Animals; Antibodies, Monoclonal; Antigens, CD; CD28 Antigens; CD3 Complex; Cell Adhesion Molecules; Cell Line, Tumor; Cell Membrane; Cell Proliferation; CHO Cells; Cricetinae; Cricetulus; Endosomes; Endothelial Cells; Humans; Mice; Microcirculation; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphorylation; T-Lymphocytes; Tyrosine | 2013 |
Xanthohumol modulates inflammation, oxidative stress, and angiogenesis in type 1 diabetic rat skin wound healing.
Topics: Angiogenesis Inducing Agents; Animals; Diabetes Mellitus, Experimental; Flavonoids; Glutathione; Hydrogen Peroxide; Inflammation; Interleukin-1beta; Liver; Male; Neovascularization, Pathologic; Oxidative Stress; Phenols; Propiophenones; Rats; Rats, Wistar; Skin; Tyrosine; Vascular Endothelial Growth Factor A; Wound Healing | 2013 |
Tyrosine phosphorylation modulates the vascular responses of mesenteric arteries from human colorectal tumors.
Topics: Colorectal Neoplasms; Gene Expression Regulation, Neoplastic; Humans; Mesenteric Arteries; Neovascularization, Pathologic; Organ Culture Techniques; Phosphorylation; Tyrosine; Vanadates; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2013 |
Profilin-1 phosphorylation directs angiocrine expression and glioblastoma progression through HIF-1α accumulation.
Topics: Animals; Autocrine Communication; Brain Neoplasms; Capillary Permeability; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Disease Progression; Endothelial Cells; Female; Glioblastoma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Neoplasm Grading; Neovascularization, Pathologic; Phosphorylation; Profilins; RNA Interference; Time Factors; Transfection; Tumor Burden; Tumor Microenvironment; Tyrosine; Up-Regulation; Von Hippel-Lindau Tumor Suppressor Protein | 2014 |
Focal adhesion kinase: an alternative focus for anti-angiogenesis therapy in ovarian cancer.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Ovarian Epithelial; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Focal Adhesion Protein-Tyrosine Kinases; Gene Dosage; Humans; Indoles; Mice, Nude; Neoplasm Metastasis; Neoplasms, Glandular and Epithelial; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphorylation; Protein Kinase Inhibitors; Sulfonamides; Tyrosine | 2014 |
Endothelium-derived nitric oxide (NO) activates the NO-epidermal growth factor receptor-mediated signaling pathway in bradykinin-stimulated angiogenesis.
Topics: Angiogenesis Inducing Agents; Animals; Bradykinin; Cell Proliferation; ErbB Receptors; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neovascularization, Pathologic; Neovascularization, Physiologic; Nitric Oxide; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Proto-Oncogene Proteins p21(ras); Rabbits; S-Nitrosothiols; Signal Transduction; Tyrosine | 2014 |
Carbon monoxide inhibits sprouting angiogenesis and vascular endothelial growth factor receptor-2 phosphorylation.
Topics: Animals; Carbon Monoxide; Cell Movement; Cell Proliferation; Collagen; Drug Combinations; Endothelial Cells; Human Umbilical Vein Endothelial Cells; Humans; Immunoprecipitation; Laminin; Mice, Inbred C57BL; Neovascularization, Pathologic; Organometallic Compounds; Phosphorylation; Proteoglycans; Recombinant Proteins; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2015 |
Tanshinone I inhibits tumor angiogenesis by reducing Stat3 phosphorylation at Tyr705 and hypoxia-induced HIF-1α accumulation in both endothelial and tumor cells.
Topics: Abietanes; Animals; Antineoplastic Agents, Phytogenic; Aorta; Apoptosis; Blotting, Western; Cell Movement; Cell Proliferation; Chickens; Chorioallantoic Membrane; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Small Interfering; STAT3 Transcription Factor; Tumor Cells, Cultured; Tyrosine | 2015 |
Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress.
Topics: Animals; Diabetic Nephropathies; Fibrosis; Gene Transfer Techniques; Genetic Therapy; Kallikreins; Kidney; Kidney Function Tests; Male; Mice, Inbred C57BL; Mice, Transgenic; NADPH Oxidase 4; NADPH Oxidases; Neovascularization, Pathologic; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products; Serpins; Transforming Growth Factor beta; Tyrosine; Vascular Endothelial Growth Factor A | 2016 |
N-acetylcysteine modulates angiogenesis and vasodilation in stomach such as DNA damage in blood of portal hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Blotting, Western; Comet Assay; Disease Models, Animal; DNA Damage; Gastric Mucosa; Hypertension, Portal; Immunohistochemistry; Male; Neovascularization, Pathologic; Nitric Oxide Synthase Type III; Portal Pressure; Rats, Wistar; Stomach; Tyrosine; Vascular Endothelial Growth Factor A; Vasodilation | 2015 |
Effect of tyrosine-rich amelogenin peptide on behavior and differentiation of endothelial cells.
Topics: Amelogenin; Biomarkers; Cell Differentiation; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Dental Enamel Proteins; Endothelial Cells; Humans; In Vitro Techniques; Neovascularization, Pathologic; Tyrosine; Umbilical Veins | 2016 |
A key tyrosine (Y1494) in the beta4 integrin regulates multiple signaling pathways important for tumor development and progression.
Topics: Breast Neoplasms; Cell Line, Tumor; Disease Progression; Extracellular Signal-Regulated MAP Kinases; Humans; Immunohistochemistry; Integrin alpha6beta4; Neovascularization, Pathologic; Phosphatidylinositol 3-Kinases; Signal Transduction; src-Family Kinases; Tyrosine | 2008 |
IQGAP1-dependent signaling pathway regulates endothelial cell proliferation and angiogenesis.
Topics: Animals; Blotting, Western; Cell Proliferation; Chickens; Endothelial Cells; Humans; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-cbl; ras GTPase-Activating Proteins; Signal Transduction; src-Family Kinases; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2008 |
FAK mediates the inhibition of glioma cell migration by truncated 24 kDa FGF-2.
Topics: Cell Line, Tumor; Cell Movement; Fibroblast Growth Factor 2; Focal Adhesion Kinase 1; Focal Adhesion Kinase 2; Glioma; Humans; Neovascularization, Pathologic; Phosphorylation; Phosphotyrosine; Serine; Tyrosine | 2009 |
A gamma-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Animals; Antioxidants; Apoptosis; Benzo(a)pyrene; Cell Line, Tumor; Cell Proliferation; Deoxyguanosine; Dinoprostone; Female; gamma-Tocopherol; Histones; Leukotriene B4; Lung Neoplasms; Mice; Neovascularization, Pathologic; Nitrosamines; Tyrosine; Xenograft Model Antitumor Assays | 2010 |
Bee venom inhibits tumor angiogenesis and metastasis by inhibiting tyrosine phosphorylation of VEGFR-2 in LLC-tumor-bearing mice.
Topics: Animals; Bee Venoms; Carcinoma, Lewis Lung; Cell Movement; Cell Survival; Male; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neovascularization, Pathologic; Phosphorylation; Protein Tyrosine Phosphatases; Signal Transduction; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation.
Topics: Animals; Cell Movement; Cell Proliferation; Cell Survival; Cells, Cultured; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Lymphokines; Mice; Neovascularization, Pathologic; Phosphorylation; Platelet-Derived Growth Factor; Proto-Oncogene Proteins c-akt; Receptor, Platelet-Derived Growth Factor beta; Retinal Vessels; Serine; Tyrosine; Up-Regulation | 2010 |
Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis.
Topics: Antigens, CD34; Biomarkers, Tumor; Bone Neoplasms; Chondrosarcoma; Cyclooxygenase 2; Humans; Immunohistochemistry; Neoplasm Staging; Neovascularization, Pathologic; Nitric Oxide Synthase; Predictive Value of Tests; Prognosis; Survival Analysis; Tyrosine | 2010 |
Design, synthesis, and biological evaluation of dibromotyrosine analogues inspired by marine natural products as inhibitors of human prostate cancer proliferation, invasion, and migration.
Topics: Angiogenesis Inhibitors; Animals; Binding Sites; Biological Products; Cell Line, Tumor; Cell Movement; Cell Proliferation; Computer Simulation; Drug Design; Humans; Male; Neovascularization, Pathologic; Porifera; Prostatic Neoplasms; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2010 |
c-Cbl inhibits angiogenesis and tumor growth by suppressing activation of PLCγ1.
Topics: Animals; Cell Division; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Phospholipase C gamma; Phosphorylation; Proto-Oncogene Proteins c-cbl; Signal Transduction; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2011 |
Docking protein Gab1 is an essential component of postnatal angiogenesis after ischemia via HGF/c-met signaling.
Topics: Adaptor Proteins, Signal Transducing; Animals; Animals, Newborn; Arteries; Carrier Proteins; Class Ia Phosphatidylinositol 3-Kinase; Endothelial Cells; Endothelium, Vascular; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Hepatocyte Growth Factor; Hindlimb; Humans; Ischemia; Male; Mice; Mice, Knockout; Mice, Transgenic; Neovascularization, Pathologic; Phosphoproteins; Phosphorylation; Regional Blood Flow; SH2 Domain-Containing Protein Tyrosine Phosphatases; Signal Transduction; Tyrosine | 2011 |
Sunitinib suppresses tumor growth and metastases in a highly metastatic mouse mammary cancer model.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Blotting, Western; Body Weight; Female; Humans; Immunoenzyme Techniques; Indoles; Lymphatic Metastasis; Lymphatic Vessels; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Pyrroles; Sunitinib; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2011 |
Tyrosine-phosphorylated galectin-3 protein is resistant to prostate-specific antigen (PSA) cleavage.
Topics: Cell Line, Tumor; Chemotaxis; Extracellular Space; Galectin 3; Humans; Models, Molecular; Neovascularization, Pathologic; Phosphoric Monoester Hydrolases; Phosphorylation; Prostate-Specific Antigen; Protein Conformation; Proteolysis; Proto-Oncogene Proteins c-abl; PTEN Phosphohydrolase; Tyrosine | 2012 |
Trehalose treatment accelerates the healing of UVB-irradiated corneas. Comparative immunohistochemical studies on corneal cryostat sections and corneal impression cytology.
Topics: Animals; Apoptosis; Biomarkers; Caspase 3; Corneal Diseases; Cytodiagnosis; Epithelium, Corneal; Female; Frozen Sections; Immunohistochemistry; Injections, Intraocular; Malondialdehyde; Neovascularization, Pathologic; Oxidative Stress; Rabbits; Radiation Injuries, Experimental; Trehalose; Tyrosine; Ultraviolet Rays; Urokinase-Type Plasminogen Activator; Wound Healing | 2012 |
Tyrosine phosphorylation of DEP-1/CD148 as a mechanism controlling Src kinase activation, endothelial cell permeability, invasion, and capillary formation.
Topics: Antigens, CD; Blotting, Western; Cadherins; Capillaries; Cell Adhesion; Cell Membrane Permeability; Cell Movement; Cell Proliferation; Cells, Cultured; Cortactin; Endothelium, Vascular; Fluorescent Antibody Technique; Human Umbilical Vein Endothelial Cells; Humans; Immunoprecipitation; Mutation; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylation; Receptor-Like Protein Tyrosine Phosphatases, Class 3; Signal Transduction; src-Family Kinases; Tyrosine; Vascular Endothelial Growth Factor A | 2012 |
Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro.
Topics: Angiogenic Proteins; Cell Proliferation; Humans; Indoles; Meningeal Neoplasms; Meningioma; Neovascularization, Pathologic; Phosphorylation; Piperazines; Proto-Oncogene Proteins c-sis; Pyrroles; Quinazolines; Receptor, Platelet-Derived Growth Factor beta; Receptors, Vascular Endothelial Growth Factor; Signal Transduction; Sunitinib; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Xanthones | 2012 |
Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1.
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Screening Assays, Antitumor; Enzyme Activation; Flavonoids; Head and Neck Neoplasms; Humans; Multiple Myeloma; Neovascularization, Pathologic; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 6; RNA, Small Interfering; STAT3 Transcription Factor; Structure-Activity Relationship; Tyrosine | 2013 |
Effect of glycation on basic fibroblast growth factor induced angiogenesis and activation of associated signal transduction pathways in vascular endothelial cells: possible relevance to wound healing in diabetes.
Topics: Animals; Cattle; Cell Division; Cells, Cultured; Diabetes Mellitus; Endothelium, Vascular; Fibroblast Growth Factor 2; Glycation End Products, Advanced; Neovascularization, Pathologic; Phosphorylation; Protein Binding; Signal Transduction; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tyrosine; Wound Healing | 2001 |
Angiogenesis stimulated by PDGF-CC, a novel member in the PDGF family, involves activation of PDGFR-alphaalpha and -alphabeta receptors.
Topics: Allantois; Animals; Blood Vessels; Chick Embryo; Chorion; Cornea; Endothelial Growth Factors; Endothelium, Vascular; Gene Expression; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Phosphorylation; Platelet Endothelial Cell Adhesion Molecule-1; Platelet-Derived Growth Factor; Protein Isoforms; Receptor, Platelet-Derived Growth Factor alpha; RNA, Messenger; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Nitric oxide pathways in human bladder carcinoma. The distribution of nitric oxide synthases, soluble guanylyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine.
Topics: Aged; Blotting, Western; Carcinoma; Cell Transformation, Neoplastic; Cyclic GMP; Free Radical Scavengers; Guanylate Cyclase; Humans; Immunohistochemistry; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase; Oxidation-Reduction; Tyrosine; Urinary Bladder Neoplasms | 2002 |
Growth and angiogenesis of human breast cancer in a nude mouse tumour model is reduced by NK4, a HGF/SF antagonist.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Adhesion; Cell Division; Cell Movement; Cytoskeletal Proteins; Disease Models, Animal; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; Hepatocyte Growth Factor; Humans; Mice; Mice, Nude; Mitogens; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-met; Survival Rate; Tumor Cells, Cultured; Tyrosine | 2003 |
The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesis in vivo.
Topics: Animals; beta-Lactamases; Blotting, Western; Cell Adhesion; Cell Division; Cell Movement; Female; Fibroblasts; Hepatocyte Growth Factor; Humans; Male; Mice; Mice, Nude; Mitogens; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphoproteins; Phosphorylation; Prostatic Neoplasms; Proto-Oncogene Proteins c-met; Survival Rate; Tumor Cells, Cultured; Tyrosine | 2003 |
Ligand-induced vascular endothelial growth factor receptor-3 (VEGFR-3) heterodimerization with VEGFR-2 in primary lymphatic endothelial cells regulates tyrosine phosphorylation sites.
Topics: Animals; Binding Sites; Cell Line; Dimerization; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Humans; Immunoblotting; Ligands; Mutation; Neovascularization, Pathologic; Peptides; Phosphorylation; Protein Structure, Tertiary; Signal Transduction; Swine; Transfection; Tyrosine; Up-Regulation; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factor Receptor-3 | 2003 |
Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule.
Topics: Angiogenesis Inhibitors; Antigens, CD; Antineoplastic Agents; Blotting, Western; Cadherins; Catechin; Cell Division; Cell Movement; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; In Vitro Techniques; Lasers; Neovascularization, Pathologic; Phosphorylation; Precipitin Tests; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Tea; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Sustained decrease in superoxide dismutase activity underlies constrictive remodeling after balloon injury in rabbits.
Topics: Animals; Catheterization; Constriction, Pathologic; Dilatation, Pathologic; Down-Regulation; Iliac Artery; Neovascularization, Pathologic; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Oxidative Stress; Rabbits; Superoxide Dismutase; Tunica Intima; Tunica Media; Tyrosine | 2003 |
Induction of macrophage migration inhibitory factor by lysophosphatidic acid: relevance to tumor growth and angiogenesis.
Topics: Animals; Cell Division; Cell Line, Tumor; Cyclin D1; DNA; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Immunoblotting; Lysophospholipids; Macrophage Migration-Inhibitory Factors; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphorylation; ras Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Double-Stranded; RNA, Messenger; Signal Transduction; Time Factors; Transfection; Tyrosine; Up-Regulation; Vascular Endothelial Growth Factor A | 2003 |
Human apolipoprotein(a) kringle V inhibits angiogenesis in vitro and in vivo by interfering with the activation of focal adhesion kinases.
Topics: Actins; Amino Acid Sequence; Animals; Apolipoproteins; Apoprotein(a); Blotting, Western; Cell Movement; Cells, Cultured; Chick Embryo; Chorion; Collagen; DNA, Complementary; Dose-Response Relationship, Drug; Drug Combinations; Electrophoresis, Polyacrylamide Gel; Endothelium, Vascular; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Genetic Vectors; Humans; Kringles; Laminin; Lipoprotein(a); Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Neovascularization, Pathologic; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Proteoglycans; Recombinant Proteins; Time Factors; Tyrosine; Umbilical Veins; Wound Healing | 2004 |
Psammaplin A, a marine natural product, inhibits aminopeptidase N and suppresses angiogenesis in vitro.
Topics: Angiogenesis Inhibitors; Animals; Capillaries; Cattle; CD13 Antigens; Cell Division; Cell Line, Tumor; Cells, Cultured; Disulfides; Dose-Response Relationship, Drug; Endothelial Cells; Fibroblast Growth Factor 2; In Vitro Techniques; Inhibitory Concentration 50; Models, Chemical; Neoplasm Invasiveness; Neovascularization, Pathologic; Porifera; Tyrosine | 2004 |
Antioxidant intervention attenuates myocardial neovascularization in hypercholesterolemia.
Topics: Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Cardiotonic Agents; Coronary Circulation; Diet, Atherogenic; Dinoprost; Enzyme Induction; Female; Gene Expression Profiling; Gene Expression Regulation; Heart; Hypercholesterolemia; Hypoxia-Inducible Factor 1, alpha Subunit; Imaging, Three-Dimensional; Myocardial Ischemia; Neovascularization, Pathologic; Oxidative Stress; Superoxide Dismutase; Swine; Tomography, X-Ray Computed; Transcription Factors; Tyrosine; Vascular Endothelial Growth Factor A; Vitamin E | 2004 |
Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Topics: Animals; Apoptosis; Blood Vessels; Cell Division; Cell Line, Tumor; Cell Movement; Endothelium, Vascular; Ephrin-B2; Green Fluorescent Proteins; Humans; Luminescent Proteins; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Phosphorylation; Receptor, EphB4; Recombinant Proteins; Signal Transduction; Tyrosine; Umbilical Veins | 2004 |
Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Blotting, Western; Butadienes; Cell Division; Cell Line, Tumor; Chromones; Deoxycytidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Epidermal Growth Factor; ErbB Receptors; Gemcitabine; Humans; Hypoxia; Mitogen-Activated Protein Kinases; Morpholines; Neovascularization, Pathologic; NF-kappa B; Nitriles; Oxygen; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Signal Transduction; Sp1 Transcription Factor; Time Factors; Tyrosine | 2004 |
Matrix-bound sixth Ig-like domain of cell adhesion molecule L1 acts as an angiogenic factor by ligating alphavbeta3-integrin and activating VEGF-R2.
Topics: Angiogenesis Inducing Agents; Animals; Cells, Cultured; Chickens; Chorioallantoic Membrane; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Growth Substances; Immunoblotting; Immunoglobulins; Immunoprecipitation; Integrin alphaVbeta3; Ligands; Neovascularization, Pathologic; Neural Cell Adhesion Molecule L1; Phosphorylation; Protein Binding; Protein Structure, Tertiary; Tyrosine; Up-Regulation; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
Anticancer effects of ZD6474, a VEGF receptor tyrosine kinase inhibitor, in gefitinib ("Iressa")-sensitive and resistant xenograft models.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gefitinib; Lung Neoplasms; Mice; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Piperidines; Quinazolines; Receptors, Vascular Endothelial Growth Factor; Tumor Cells, Cultured; Tyrosine; Xenograft Model Antitumor Assays | 2004 |
KRN633: A selective inhibitor of vascular endothelial growth factor receptor-2 tyrosine kinase that suppresses tumor angiogenesis and growth.
Topics: Angiogenesis Inhibitors; Animals; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Enzyme Activation; Humans; Lung Neoplasms; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphorylation; Prostatic Neoplasms; Quinazolines; Rats; Rats, Nude; Transplantation, Heterologous; Tyrosine; Umbilical Veins; Vascular Endothelial Growth Factor Receptor-2 | 2004 |
Pigment epithelium-derived factor inhibits fibroblast-growth-factor-2-induced capillary morphogenesis of endothelial cells through Fyn.
Topics: Animals; Brain; Capillaries; Cells, Cultured; Collagen; DNA-Binding Proteins; DNA, Complementary; Down-Regulation; Drug Combinations; Endothelium, Vascular; Eye Proteins; Fibroblast Growth Factor 2; Fluorescent Antibody Technique, Indirect; GTPase-Activating Proteins; Guanine Nucleotide Exchange Factors; Humans; Immunoblotting; Immunoprecipitation; Laminin; Mice; Neovascularization, Pathologic; Neovascularization, Physiologic; Nerve Growth Factors; Nuclear Proteins; Phosphorylation; Protein Structure, Tertiary; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-fyn; Pyrimidines; Recombinant Proteins; Repressor Proteins; Serpins; Signal Transduction; src-Family Kinases; Transfection; Tyrosine; Umbilical Veins | 2005 |
VEGF receptor-2 Y951 signaling and a role for the adapter molecule TSAd in tumor angiogenesis.
Topics: Actins; Adaptor Proteins, Signal Transducing; Amino Acid Sequence; Animals; Binding Sites; Cell Line, Tumor; Cells, Cultured; Endothelial Cells; Fibrosarcoma; Humans; Kidney Neoplasms; Mice; Molecular Sequence Data; Neovascularization, Pathologic; Phosphorylation; RNA, Small Interfering; Signal Transduction; Stem Cells; Tyrosine; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Semaphorin 4D/plexin-B1 induces endothelial cell migration through the activation of PYK2, Src, and the phosphatidylinositol 3-kinase-Akt pathway.
Topics: Animals; Antigens, CD; Cell Line; Cell Membrane; Cell Movement; Cytoplasm; Endothelium, Vascular; Enzyme Activation; Focal Adhesion Kinase 2; Genes, Dominant; Hepatocyte Growth Factor; Humans; Immunoblotting; Immunoprecipitation; Neovascularization, Pathologic; Nerve Tissue Proteins; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Receptor, trkA; Receptors, Cell Surface; Recombinant Fusion Proteins; Semaphorins; src-Family Kinases; Swine; Time Factors; Tyrosine | 2005 |
Evaluation of potential Stat3-regulated genes in human breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Blotting, Western; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Lymph Nodes; Lymphatic Metastasis; Male; Mice; Mice, Nude; Middle Aged; Neovascularization, Pathologic; Oligonucleotide Array Sequence Analysis; Phosphorylation; Proto-Oncogene Mas; Receptors, Estrogen; Receptors, Progesterone; Signal Transduction; STAT3 Transcription Factor; Trans-Activators; Tyrosine | 2005 |
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Biological Assay; Cell Adhesion; Cell Line; Cell Line, Tumor; Cell Proliferation; Chick Embryo; Chorioallantoic Membrane; Endothelial Cells; Humans; Mice; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Saponins; Sea Cucumbers; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2005 |
Hypoxia-inducible factor 1alpha modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells.
Topics: Adenoviridae; Animals; Aorta; Blotting, Western; Cattle; Cell Adhesion; Cell Movement; Cells, Cultured; Cobalt; DNA, Complementary; Endothelium, Vascular; Focal Adhesion Protein-Tyrosine Kinases; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunoblotting; Immunoprecipitation; Luciferases; Microscopy, Fluorescence; Muscle, Smooth; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neovascularization, Pathologic; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transfection; Tyrosine; Vascular Endothelial Growth Factor A; Wound Healing | 2005 |
A single amino acid substitution in the activation loop defines the decoy characteristic of VEGFR-1/FLT-1.
Topics: Amino Acid Sequence; Animals; Asparagine; Aspartic Acid; Blotting, Western; Cell Membrane; Cell Proliferation; Cell Transformation, Neoplastic; Culture Media, Serum-Free; Dose-Response Relationship, Drug; Enzyme Activation; Fibroblasts; Humans; Immunoprecipitation; Ligands; Mice; Molecular Sequence Data; Mutation; Neovascularization, Pathologic; NIH 3T3 Cells; Phosphorylation; Protein Structure, Tertiary; Protein-Tyrosine Kinases; Receptor Protein-Tyrosine Kinases; Recombinant Fusion Proteins; Sequence Homology, Amino Acid; Thymidine; Time Factors; Tyrosine; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2 | 2006 |
Withdrawal: Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1.
Topics: Amyloid Precursor Protein Secretases; Animals; Blotting, Western; Cattle; Cell Membrane; Cell Movement; Cell Nucleus; Cell Proliferation; Cells, Cultured; Collagen; Cytoskeleton; Cytosol; Drug Combinations; Endopeptidases; Endothelium, Vascular; Eye Proteins; Growth Substances; Immunohistochemistry; Immunoprecipitation; Laminin; Membrane Proteins; Microcirculation; Neovascularization, Pathologic; Nerve Growth Factors; Oligonucleotides, Antisense; Phosphorylation; Presenilin-1; Protein Structure, Tertiary; Protein Transport; Proteoglycans; Serpins; Signal Transduction; Subcellular Fractions; Substrate Specificity; Time Factors; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Wound Healing | 2006 |
Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaB.
Topics: Adenoviridae; Apoptosis; Blotting, Western; Cell Survival; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Humans; Luciferases; Neovascularization, Pathologic; NF-kappa B; Phosphorylation; RNA, Messenger; Signal Transduction; Time Factors; Transcription Factor RelA; Transcription Factors; Transcription, Genetic; Tyrosine; Umbilical Veins; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Topics: Antigens, CD; Cadherins; Cell Adhesion; Cell Membrane; Cytoplasm; Ephrin-A1; Humans; Intercellular Junctions; Melanoma; Neovascularization, Pathologic; Oligonucleotides, Antisense; Phosphorylation; Receptor, EphA2; Signal Transduction; Skin Neoplasms; Tumor Cells, Cultured; Tyrosine | 2006 |
Bastadin 6, a spongean brominated tyrosine derivative, inhibits tumor angiogenesis by inducing selective apoptosis to endothelial cells.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Growth Processes; Cornea; Endothelial Cells; Fibroblast Growth Factor 2; Halogenated Diphenyl Ethers; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Neovascularization, Physiologic; NIH 3T3 Cells; Porifera; Rats; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2006 |
Intrinsic FAK activity and Y925 phosphorylation facilitate an angiogenic switch in tumors.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Line, Transformed; Cell Line, Tumor; Cells, Cultured; Clone Cells; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Mammary Neoplasms, Animal; Mice; Mice, Inbred BALB C; Mice, Nude; Neovascularization, Pathologic; Phosphorylation; Protein-Tyrosine Kinases; Signal Transduction; Tyrosine | 2006 |
Stromal cell-derived factor-1/chemokine (C-X-C motif) ligand 12 stimulates human hepatoma cell growth, migration, and invasion.
Topics: Carcinoma, Hepatocellular; Cell Movement; Cell Proliferation; Chemokine CXCL12; Chemokines, CXC; Flow Cytometry; Fluorescent Antibody Technique; Glycosaminoglycans; Humans; Liver Neoplasms; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neovascularization, Pathologic; Phosphorylation; Receptors, CXCR4; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Messenger; Stromal Cells; Syndecan-1; Syndecan-2; Syndecan-4; Tyrosine | 2007 |
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
Topics: Animals; Antibodies; Brain Neoplasms; Cell Line, Tumor; Choline; Fibronectins; Glioma; Male; Neovascularization, Pathologic; Radiopharmaceuticals; Rats; Rats, Wistar; Recombinant Fusion Proteins; Tyrosine | 2007 |
Hrs is a positive regulator of VEGF and insulin signaling.
Topics: Binding Sites; Cell Line; Diabetic Retinopathy; Endosomal Sorting Complexes Required for Transport; Gene Expression Regulation; GRB10 Adaptor Protein; Humans; Insulin; Nedd4 Ubiquitin Protein Ligases; Neovascularization, Pathologic; Phosphoproteins; Phosphorylation; Protein Structure, Tertiary; Receptor, Insulin; Signal Transduction; Tyrosine; Ubiquitin; Ubiquitin-Protein Ligases; Up-Regulation; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2007 |
Gambogic acid inhibits angiogenesis through suppressing vascular endothelial growth factor-induced tyrosine phosphorylation of KDR/Flk-1.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Chick Embryo; Collagen; Drug Combinations; Endothelium, Vascular; Female; Humans; Laminin; Lung Neoplasms; Male; Mice; Neovascularization, Pathologic; Phosphorylation; Proteoglycans; Tyrosine; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Xanthones | 2007 |
S100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation.
Topics: Animals; Blotting, Western; Breast Neoplasms; Calcium-Binding Proteins; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Down-Regulation; Drug Combinations; Epidermal Growth Factor; ErbB Receptors; Female; Humans; Immunoblotting; Interleukin-8; Laminin; Mice; Mice, SCID; Neovascularization, Pathologic; Osteoclasts; Osteolysis; Phosphorylation; Proteoglycans; Receptor, ErbB-2; S100 Calcium Binding Protein A7; S100 Proteins; Signal Transduction; Tyrosine | 2008 |
Identification and functional analysis of phosphorylated tyrosine residues within EphA2 receptor tyrosine kinase.
Topics: Amino Acid Substitution; Animals; Cell Movement; Endothelial Cells; Ephrin-A1; Guanine Nucleotide Exchange Factors; Mice; Mice, Transgenic; Mutation, Missense; Neoplasm Invasiveness; Neovascularization, Pathologic; Neuropeptides; Peptide Mapping; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Binding; Protein Structure, Tertiary; Proto-Oncogene Proteins c-vav; rac GTP-Binding Proteins; rac1 GTP-Binding Protein; Receptor, EphA2; Signal Transduction; Tyrosine | 2008 |
New sulfonated distamycin A derivatives with bFGF complexing activity.
Topics: 3T3 Cells; Animals; Binding, Competitive; Distamycins; Fibroblast Growth Factor 2; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phosphorylation; Structure-Activity Relationship; Sulfonic Acids; Suramin; Tyrosine | 1994 |
Evidence for nutrient modulation of tumor phenotype: impact of tyrosine and phenylalanine restriction.
Topics: Animal Nutritional Physiological Phenomena; Animals; Diet; Female; Killer Cells, Natural; Lung; Mast Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Phenotype; Phenylalanine; Tumor Cells, Cultured; Tyrosine | 1994 |
Angiogenesis: role of calcium-mediated signal transduction.
Topics: Aminoimidazole Carboxamide; Calcium; Calcium Channel Blockers; Cell Adhesion; Cell Division; Cell Movement; Cells, Cultured; Collagen; Drug Combinations; Endothelium, Vascular; Extracellular Matrix Proteins; Fibroblast Growth Factor 2; Gelatinases; Humans; In Vitro Techniques; Laminin; Matrix Metalloproteinase 2; Metalloendopeptidases; Neovascularization, Pathologic; Phosphotyrosine; Proteoglycans; Signal Transduction; Triazoles; Tyrosine | 1995 |
Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Cell Hypoxia; Endothelial Growth Factors; Genistein; Isoflavones; Lymphokines; Mice; Molecular Sequence Data; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins pp60(c-src); RNA, Messenger; Signal Transduction; Transfection; Tumor Cells, Cultured; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1995 |
Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Topics: Adenoma; Blotting, Western; Carcinoma; Colon; Colonic Neoplasms; Disease Progression; DNA Primers; DNA, Neoplasm; Endothelial Growth Factors; Endothelium, Vascular; Humans; Immunohistochemistry; Lymphokines; Neoplasm Proteins; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phosphorylation; Polymerase Chain Reaction; Tyrosine; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1998 |
HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Topics: Allantois; Angiogenesis Inhibitors; Animals; Antibodies; Carcinoma, Lewis Lung; Cell Movement; Chick Embryo; CHO Cells; Chorion; Cricetinae; Endothelium, Vascular; Enzyme Activation; Growth Inhibitors; Hepatocyte Growth Factor; Humans; Lung Neoplasms; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Phosphorylation; Proto-Oncogene Proteins c-met; Rabbits; Recombinant Proteins; Tyrosine | 2000 |
Expression of nitric oxide synthases and nitrotyrosine during blood-brain barrier breakdown and repair after cold injury.
Topics: Animals; Blood-Brain Barrier; Brain Edema; Cerebral Cortex; Cold Temperature; Gene Expression; Immunohistochemistry; Male; Neovascularization, Pathologic; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Wistar; RNA, Messenger; Time Factors; Tyrosine | 2001 |
Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).
Topics: Humans; Melanoma; Neovascularization, Pathologic; Oligonucleotides, Antisense; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptor, EphA2; Tumor Cells, Cultured; Tyrosine; Uveal Neoplasms | 2001 |
Nitric oxide modulates capillary formation at the endothelial cell-tumor cell interface.
Topics: Capillaries; Carcinoma, Small Cell; Cells, Cultured; Coculture Techniques; Endothelial Growth Factors; Endothelium, Vascular; Fibroblast Growth Factor 2; Humans; Lung Neoplasms; Lymphokines; Matrix Metalloproteinases; Neovascularization, Pathologic; Nitric Oxide; Osmolar Concentration; Phosphorylation; Pulmonary Circulation; Tyrosine; Umbilical Veins; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |
Microvascular endothelial cells differ in basal and hypoxia-regulated expression of angiogenic factors and their receptors.
Topics: Angiopoietin-1; Angiopoietin-2; Animals; Aryl Hydrocarbon Receptor Nuclear Translocator; Binding, Competitive; Blotting, Western; Cattle; Cells, Cultured; Cloning, Molecular; Corpus Luteum; DNA-Binding Proteins; DNA, Complementary; Endothelium, Vascular; Female; fms-Like Tyrosine Kinase 3; Humans; Hypoxia; Keratins; Membrane Glycoproteins; Neovascularization, Pathologic; Phenotype; Phosphorylation; Precipitin Tests; Protein Biosynthesis; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptor, TIE-2; Receptors, Aryl Hydrocarbon; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Messenger; Temperature; Transcription Factors; Tyrosine; Vascular Endothelial Growth Factor Receptor-1 | 2002 |
Inhibition of angiogenesis by the antiepidermal growth factor receptor antibody ImClone C225 in androgen-independent prostate cancer growing orthotopically in nude mice.
Topics: Androgens; Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Apoptosis; Blood Vessels; Cell Cycle Proteins; Cell Division; Cetuximab; Cyclin-Dependent Kinase Inhibitor p27; Dose-Response Relationship, Drug; Epidermal Growth Factor; ErbB Receptors; Humans; Interleukin-8; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; Neoplasm Transplantation; Neovascularization, Pathologic; Paclitaxel; Phosphorylation; Prostatic Neoplasms; RNA, Messenger; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tyrosine; Up-Regulation; Xenograft Model Antitumor Assays | 2002 |
Induction of angiogenesis in vitro by vanadate, an inhibitor of phosphotyrosine phosphatases.
Topics: Animals; Cells, Cultured; Collagen; Endothelium, Vascular; Microscopy, Electron; Microscopy, Phase-Contrast; Neovascularization, Pathologic; Nucleic Acid Hybridization; Phenotype; Phosphoprotein Phosphatases; Phosphorylation; Plasminogen Activators; Protein Tyrosine Phosphatases; RNA, Messenger; Transcription, Genetic; Tyrosine; Vanadates | 1988 |